Ascendia

  MARKET NEWS

QSAM Biosciences Opens Enrollment of the Second Cohort of Patients in its Phase 1 Study of Targeting Metastatic Bone Cancer
AI Therapeutics Announces Positive Results From Phase 2a Biomarker-Driven Trial of AIT-101 in Patients with C9ORF72 Amyotrophic Lateral Sclerosis
RespireRx Pharmaceuticals Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
Zevra Therapeutics Announces Submission of IND for KP1077 in Narcolepsy
Caribou Biosciences Announces FDA Granted Fast Track Designation for Allogeneic CAR-T Cell Therapy for Relapsed or Refractory Multiple Myeloma
Eckert & Ziegler to Supply POINT Biopharma With Actinium-225

  FEATURED EDITORIAL

  COMPANY PROFILE

PCI is as a leading global CDMO, truly spanning the cycle, connecting development and commercialization, de-risking the supply chain providing clients with integrated end-to-end drug development, manufacturing and packaging capabilities that increase their products’ speed to market and opportunities for commercial success. PCI brings the proven experience that comes with more than 90 successful product launches each year and over five decades in the healthcare services business. Leading technology and continued investment enable us to address global outsourcing needs throughout the product lifecycle. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Celanese Announces Agreement With Glaukos Corporation for Sustained-Release Glaucoma Treatment

Celanese Announces Agreement With Glaukos Corporation for Sustained-Release Glaucoma Treatment

Celanese Corporation, a global specialty materials and chemical company, recently announced it has entered into an agreement with Glaukos Corporation to supply its VitalDose® Drug Delivery Platform for use as….

Bora Pharmaceuticals & Celltrion Partner to Expand OSD Capabilities in APAC Market

Bora Pharmaceuticals & Celltrion Partner to Expand OSD Capabilities in APAC Market

Bora Pharmaceuticals Co., Ltd. and Celltrion Asia Pacific Pte., Ltd. recently announced their partnership to contract manufacture and commercialize a range of oral dosage form drugs (OSD) across the APAC region…..

Lonza & ABL Bio Collaborate in the Development & Manufacture of Bispecific Antibody Product

Lonza & ABL Bio Collaborate in the Development & Manufacture of Bispecific Antibody Product

Lonza recently announced it has an agreement with ABL Bio to support the development and manufacturing of ABL Bio’s new bispecific antibody product….

Absci Partners With Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology

Absci Partners With Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology

Absci Corporation and M2GEN recently announced a partnership to create new cancer medicines and bring them to market at unprecedented speed. Absci’s generative AI drug creation platform will tap into M2GEN’s clinical and….

  WHITEPAPERS & WEBINARS

WHITEPAPER - Unique Manufacturing Challenges Associated With Sterile Eye Ointments

WHITEPAPER - Unique Manufacturing Challenges Associated With Sterile Eye Ointments

The manufacture of ophthalmic ointments is much more complex than the production of ocular liquid therapies and presents several unique challenges. It is essential for drug developers to choose outsourcing partners with extensive manufacturing experience with these specialized capabilities in …

WHITEPAPER - Improve Process Economics & Enable High Protein Concentrations

WHITEPAPER - Improve Process Economics & Enable High Protein Concentrations

This white paper evaluates the effect of the excipients in the Viscosity Reduction Platform on ultrafiltration processes used to produce a highly concentrated formulation of a monoclonal antibody (mAb). Two filtration methods are demonstrated in this work.

Click here to …

WHITEPAPER - Purity is Paramount: Assessing N-Oxide Impurities in Lipids Used in Lipid Nanoparticle Delivery Systems

WHITEPAPER - Purity is Paramount: Assessing N-Oxide Impurities in Lipids Used in Lipid Nanoparticle Delivery Systems

By: Sabrina Metze, PhD, Ulrich Klöckner, PhD, Lars Geiger, PhD, Justin Schieven, PhD, and Thomas Böhmer*

Summary

The quality of lipids in a lipid nanoparticle assembly is critically important to the functionality of mRNA-based therapeutics. Packer et al. have identified …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

April 19 – Prefilled Syringes
April 26 – Particle Design Technology